US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Marker Therapeutics (delisted) (TPIV)
Marker Therapeutics (delisted) (TPIV) ニュース

TPIV

TapImmune, Inc. (TPIV)

Marker Therapeutics (delisted)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TPIV

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2018/10/20	06 : 10	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/20	05 : 55	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/20	05 : 53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/20	05 : 34	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/20	05 : 33	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/20	05 : 31	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/19	05 : 54	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/19	05 : 54	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/19	05 : 54	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/19	05 : 54	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/19	05 : 53	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/19	05 : 52	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/19	05 : 52	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/19	05 : 51	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/19	05 : 51	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/19	05 : 51	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/19	05 : 50	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/19	05 : 50	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/19	05 : 49	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/18	05 : 02	Edgar (US Regulatory)	Amended Securities Registration (section 12(b)) (8-a12b/a)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/18	05 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/18	00 : 45	PR Newswire (US)	TapImmune And Marker Therapeutics Announce Successful Closing Of Previously Announced Merger And Financing	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/17	21 : 56	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/17	21 : 54	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/17	21 : 52	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/17	21 : 49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/17	21 : 47	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/11	05 : 53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/10/10	19 : 30	PR Newswire (US)	TapImmune's HER2/neu-Targeted Breast Cancer Vaccine to be Studied in a Large Phase 2 Immunotherapy Combination Study Funded b...	NASDAQ:TPIV	Marker Therapeutics (delisted)
2018/09/26	06 : 05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:TPIV	Marker Therapeutics (delisted)

Showing the most relevant articles for your search:NASDAQ:TPIV

1 2 3 4 5 6 7 8 9 10 次へ >>

Deutsche Telekom (QX)

Bank of America

US Dollar vs Sterling

Invesco QQQ Trust Series 1

American Express

Energy Select Sector SPDR

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約